China's A-share pharmaceutical industry chain continues to strengthen, with Chimin and CMC hitting the daily limit, following TJPC, YIBAI PHARMACEUTICAL, and PKU HEALTHCARE also hitting the daily limit. Previously, Huaren Health, Baheal Medical, SYPM, INNOSTIC, and HRPC, among other stocks, rose more than 5%Wallstreetcn·Apr 2 at 12:43 AM301017-0.80%600488-4.58%
INNOSTIC: The net profit for the third quarter was 92.7977 million yuan, a year-on-year increase of 49.14%Zhitong·Oct 27, 2025 at 06:32 AM301584-0.24%
INNOSTIC: The company does not have brain-computer interface products or related technology reservesZhitong·Oct 26, 2025 at 10:43 PM301584-0.24%
INNOSTIC: Currently not engaged in the business of testing reagents related to Chikungunya fever symptomsZhitong·Oct 12, 2025 at 11:09 PM301584-0.24%
On the first day of listing, the new stock of the Growth Enterprise Market, INNOSTIC, once rose over 500%, currently reported at 42.07 yuan/shareZhitong·Sep 24, 2025 at 10:24 PM301584-0.24%
September 17th New Stock Reminder: Inovance Automotive announces online lottery results and payment, INNOSTIC announces winning rateZhitong·Sep 16, 2025 at 07:14 PM301656+1.08%301584-0.24%
INNOSTIC IPO pricing at 7.05 yuan/share, subscription opens on September 16Zhitong·Sep 14, 2025 at 10:07 AM301584-0.24%
